EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2 Positive Early Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: carboplatin|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Epirubicin|DRUG: cyclophosphamide
Sponsor: Fudan University